X0303 4 2011-05-03 0 0001222244 ProUroCare Medical Inc. PUMD 0001353829 Carlson Richard Craig 810 LAKE SUSAN HILLS DRIVE CHANHASSEN MN 55317 1 1 0 0 CEO Common Stock, $0.00001 par value 850 D Stock Options 5.00 2014-02-01 Common Stock, $0.00001 par value 10000 10000 D Stock options 1.00 2015-07-11 Common stock, $0.00001 par value 70000 70000 D Stock Options 0.85 2016-03-03 Common stock, $0.00001 par value 100000 100000 D Stock options 1.5 2016-09-29 Common stock, $0.00001 par value 150000 150000 D Stock Options 0.975 2011-05-03 4 A 0 150000 0 A 2018-05-03 Common stock, $0.00001 par value 150000 150000 D The Option shall vest as enumerated: (a) 50,000 shares are vested and currently exercisable; (b) 20,000 shares vest on July 1, 2011. Immediately exercisable. Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants). The options will vest in the amounts indicated below upon achievement of the following objectives within nine months of the Company's receipt of FDA clearance to sell the ProUroScan System in the U.S.:25% vesting - upon recording $500,000 in sales, 15% vesting upon the raising of $5 million in new funding, 30% vesting upon the execution of a corporate partner agreement, 30% vesting upon the filing of three new patent applications. Richard B. Thon by power of attorney 2011-05-05